Forskning ved Københavns Universitet - Københavns Universitet

Forside

No reactive hypoglycaemia in type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

It has previously been shown that intravenous and subcutaneous administration of glucagon-like peptide (GLP)-1 concomitant with intravenous glucose results in reactive hypoglycaemia in healthy subjects. Since GLP-1 is also effective in Type 2 diabetic patients and is presently being evaluated as a therapeutic agent in this disease, it is important to investigate whether GLP-1 can cause hypoglycaemia in such patients.
OriginalsprogEngelsk
TidsskriftDiabetic Medicine
Vol/bind18
Udgave nummer2
Sider (fra-til)144-149
Antal sider6
ISSN0742-3071
StatusUdgivet - 1 feb. 2001

ID: 170290